|
HS Code |
780554 |
As an accredited 4-N-(5-Bromopyridin-2-Yl)Morpholine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 4-N-(5-Bromopyridin-2-Yl)Morpholine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
In today’s landscape of chemical research, picking the right molecular building block shapes the success of everything downstream. Organic synthesis no longer fits neatly into repetitive recipes; each method lives and dies by careful selection at the molecular level. In that sense, 4-N-(5-Bromopyridin-2-Yl)Morpholine finds its place, blending morpholine chemistry with pyridine’s versatility and a bromine substituent that often opens new reaction doors. Not every lab pursues novelty for its own sake. Plenty of researchers, myself included, care less about the latest fad and more about how a reagent actually performs in real-world settings. Digging into the specifics of this compound helps separate its hype from its real advantages.
The backbone here involves a morpholine ring—a staple in medicinal chemistry for its stability and ability to foster hydrogen bonding. Connected to that, the 5-bromopyridin-2-yl group draws attention for two reasons. The pyridine core tilts the molecule toward both biological compatibility and synthetic adaptability, while a bromine atom attached to the pyridine ring gives chemists a reliable handle for further substitution. There’s value in this kind of design. I’ve run plenty of coupling reactions where finicky starting materials drag out reaction times. The bromopyridinyl part makes this molecule more reactive toward Suzuki, Buchwald-Hartwig, or Heck couplings. Instead of wrestling with sluggish conversions, researchers who need to build more complex heterocycles enjoy better yields and cleaner separations.
Examining 4-N-(5-Bromopyridin-2-Yl)Morpholine with a critical eye isn’t about glancing at catalog numbers or purity badges. Take the purity spec: most batches designed for R&D work offer high HPLC or NMR-based purities (often reading north of 98%). This matters for practical reasons. Anything less, and you risk introducing unknown variables in your syntheses. I’ve personally watched promising routes get jammed up by impurities that block a key step or distort analysis. Physical form comes up next. The best lots arrive as a crisp solid, pale tan or slightly off-white, not oiling out or clumping up with moisture. In a pinch, solid reagents stay shelf-stable longer and weigh out more easily, which saves time on busy days. Most scientists prefer skipping elaborate pre-treatments—dosing out a clean, free-flowing powder means fewer headaches and less lost material.
Solubility draws questions, of course. Thanks to a morpholine ring, this compound keeps a foot in both polar organic and moderate aqueous territory. It tends to dissolve well in DMF, DMSO, acetonitrile, and heated ethanol. That opens the door for high-throughput screens or parallel syntheses without switching solvent systems. There aren't many reagents that can navigate both medicinal chemistry protocol and process-scale conditions with this much ease. Stability proves equally valuable. Over standard storage conditions, most batches last months in air-tight containers, with no visible decomposition. Chemical stability means more than just a long shelf life. I’ve seen fragile intermediates waste money because half a bottle goes bad before it gets used. 4-N-(5-Bromopyridin-2-Yl)Morpholine earns a nod here, especially for groups running occasional, rather than bulk, reactions.
To understand any chemical, you have to look beyond its structure and spec sheets. Real impact shows up in the types of projects where it gets chosen repeatedly. Researchers in medicinal chemistry, for one, use 4-N-(5-Bromopyridin-2-Yl)Morpholine as a starting point for new kinase inhibitor scaffolds. The bromine atom makes cross-couplings with aryl boronic acids more reliable, letting teams lay in tailored functional groups on demand. Over the years, I’ve seen this lead to fewer failed screens and crisper SAR data.
In another corner, materials chemists sometimes turn to this compound to introduce heterocyclic motifs in organic electronics or light-emitting devices. Instead of playing guessing games with unstable pyridine or morpholine derivatives, having a single reagent that welds both functionalities together saves synthetic steps and simplifies IP filings. The universality of bromide reactivity stands out. Unlike iodides, which can get sticky or overpriced, or chlorides, which are stubborn to activate, the bromide group balances cost, ease, and compatibility with widely used catalysts. I’ve watched junior scientists pick up cross-coupling protocols in weeks rather than months because they started with an easy substrate like this.
It’s easy to look at racks crammed full of pyridine bromides, but selecting the right one isn’t a coin toss. Simple 2- or 3-bromopyridines don’t bring morpholine’s hydrogen bonding or solubility perks. Switch to morpholine functionalized at other positions, and you often lose either the right electronic orientation or the sweet spot for cross-coupling success. Alternatives like 4-chloropyridin-2-yl morpholines look tempting on paper, but in my hands, they rarely reach the same yields or tolerate the same range of coupling partners. Fluoride or iodide versions sometimes give side products or need pricier promoters.
Even looking at the broader market, the trend points clear—combinations with bromide remain a sweet spot for most standard cross-coupling protocols. Synthetic chemists, protective of their time and budget, don’t bother making a switch unless the numbers prove out. Compared side by side, this compound pulls ahead for routine library generations where reproducibility means fewer headaches. I’ve lost track of how many hours get wasted debugging a reaction before learning a simple switch—choosing bromide over chloride—gives cleaner workups and more scaleable routes.
Drug discovery, always hungry for new molecular shapes, makes effective use of 4-N-(5-Bromopyridin-2-Yl)Morpholine for fragments and lead expansion. You won’t see it paraded at every conference, but researchers hunting for kinase, G-protein coupled receptor, or antimicrobial activity see real benefit from its dual-function scaffold. There’s no magic bullet here—drug design relies on tools that play well with different substitution patterns, avoid unwanted toxicity, and support quick structure confirmation. Because this compound keeps the morpholine and pyridine rings available for further derivatization, chemists patch in various groups—the result being a smoother path to libraries that actually hit biological targets. In my own experience, using this kind of intermediate, compared to fiddling with less cooperative starting materials, cuts down both analysis time and unproductive cycle repeats.
Fragment-based drug design often depends on reagents that resist decomposition under the conditions needed for fragment growing or linking. 4-N-(5-Bromopyridin-2-Yl)Morpholine steps up here, remaining robust through a handful of protecting group strategies and base-sensitive transformations. Every medicinal chemist dreads building a library only to lose half the compounds due to decomposition mid-way. Small changes in scaffold architecture take on outsized importance over multiple cycles of synthesis and screening. By choosing a scaffold such as this, labs can reduce wasted effort and focus on fine-tuning the biological properties they care most about.
Informatics-driven approaches now steer many organizations toward rational library building. Instead of randomly generating molecules, chemoinformatics suggests which building blocks maximize coverage of target chemical space. 4-N-(5-Bromopyridin-2-Yl)Morpholine checks several boxes for these systems. With a well-defined combination of hydrogen bond donors and acceptors, molecular weight in the 'sweet spot' range, and a bromide offering varied reactivity, it fits many automated analysis pipelines. I’ve worked alongside colleagues who built in silico screening cascades; time and again, this particular scaffold cropped up as a versatile and tractable node.
Data-driven design rewards reliable reagents. Models fed cleaner reactivity data from consistent compounds generate more predictive SAR results. Choosing a clean and reproducible intermediate removes one more variable. For any team balancing traditional wet lab approaches with digital informatics, those details add up—saving weeks of labor and supporting more accurate candidate selection.
In the end, real work gets done by balancing cost with capability. 4-N-(5-Bromopyridin-2-Yl)Morpholine prices in line with similar aromatic bromides, but brings extra value with its combined morpholine and pyridine architecture. Many institutions hesitate before investing in newer intermediates, waiting to see if supply chains hold steady or if quality fluctuates batch-to-batch. The current market for this class seems well-established; I’ve yet to see meaningful shortages or price spikes even as demand has picked up.
Buying in bulk often drops per-gram costs, but smaller batch availability lets academic groups participate alongside major industry labs. Anyone running exploratory syntheses, without the luxury of a bottomless budget, finds reassurance knowing they can source aliquots without burning capital on excessive stocks. This also cuts down on waste—a notorious issue in both environmental and financial terms among research labs big and small.
Not every chemical earns glowing reviews based on actual handling. Plenty of pushbutton intermediates create more trouble than they’re worth at the bench. In daily practice, 4-N-(5-Bromopyridin-2-Yl)Morpholine brings a reassuring predictability—dispensing without clumping, weighing down to milligrams without static loss, and mixing into solvents without stubborn residues. Every experienced chemist knows the frustration of spending half an afternoon coaxing a recalcitrant powder into solution or scrubbing stir bars coated with gummy byproducts. This one, in contrast, seems built for efficiency.
Yields track closely to published values, which becomes critical in workflow planning. Any deviation forces protocol rewrites and eats up already tight timelines. Several colleagues tell stories of near-heroic troubleshooting, only to discover that switching to a bromide form from a chloride freed the route from mysterious stalls. This anecdotal evidence lines up with aggregated data from large synthetic campaigns, where bromide-based intermediates routinely outperform their chlorine or non-halogenated analogs.
Wide adoption means more researchers need to practice thoughtful handling and disposal, especially with brominated compounds. Anyone conducting frequent scale-ups or repeated couplings starts to think ahead. In waste streams, brominated byproducts require attentive separation and responsible incineration or reclamation. Laboratories skilled in green chemistry can minimize waste by planning telescoped reactions and using recyclable catalysts whenever possible. While this adds complexity, it also enables deeper learning. I’ve seen firsthand how up-and-coming scientists hone their skills by designing cleaner routes and pushing for less hazardous auxiliary materials.
No chemical occupies a vacuum. The broader operating context—local regulations, cost of hazardous waste disposal, and specific equipment—shape whether this reagent slots smoothly into existing systems. Responsible stewardship means beyond following standard operating procedures; it means staying current with evolving environmental guidance and supporting supplier audits for sustainable practices.
Research moves fastest where tools match new frontiers. In just the past decade, demand for morpholine-functionalized heterocycles soared as more research groups dove into brain-penetrant drugs, imaging probes, and organic optoelectronics. Not every intermediate keeps pace. 4-N-(5-Bromopyridin-2-Yl)Morpholine manages to support several of these avenues without forcing researchers to compromise on purity, yield, or synthetic versatility. For specialty niches like targeted protein degradation or covalent inhibitor development, the adaptability of this reagent means experiments aren’t limited by a brittle core scaffold.
Young researchers often come to appreciate the value of starting with molecules that don’t sabotage their first steps. Whether constructing small sets of candidate drugs or targeting high-value modifications in late-stage functionalization, this compound stands as a solid starting point. Using robust intermediates reduces the need for tedious troubleshooting and opens more time for creative exploration.
As tools like this enter standard practice, the challenge shifts from simply sourcing the best batch to ensuring it’s used efficiently and ethically. Educational workshops and online resources now focus on route design, process intensification, and real-world troubleshooting. Sharing firsthand stories—successes and failures—gives professionals and trainees alike stronger footing. Each year brings fresh data outlining which methods mesh best with bromopyridinyl intermediates, what purification tweaks offer the best yields, and which unexpected pitfalls still catch advanced practitioners off guard.
Groups building up high-throughput platforms or translating synthetic wins to process scale find that decisions made at the early reagent stage pay outsized dividends. That means more than just selecting a product based on headline purity; it means thinking through risk assessments, scaling studies, and long-term storage. Cutting corners on well-proven intermediates rarely pays off. Having spent years in both bench and management roles, I can say confidently: putting in the homework at the product selection phase always pays off in cycle time saved and projects completed.
Community engagement helps drive up standards for performance and safety alike. As more research is published deploying 4-N-(5-Bromopyridin-2-Yl)Morpholine in everything from new antibiotics to advanced materials, benchmarks form that guide best practice. Conferences, technical forums, and peer-reviewed papers all serve as repositories for troubleshooting insight and reliable methods. No one works in a vacuum, and crowd-sourced data sets allow each group to test and adapt findings in their own laboratories.
Transparency with successes and setbacks alike accelerates the improvement of routings, purification approaches, and even environmental handling strategies. As a part of the broader research community, I’ve learned valuable lessons both from sharing details about a failed scale-up and from adopting more effective techniques based on another lab’s experience. This sort of sharing ensures that high-value intermediates like this morpholine derivative support breakthroughs instead of stalling them at a technical or logistical roadblock.
Tools that deliver reliability under actual working conditions form the backbone of successful chemical innovation. 4-N-(5-Bromopyridin-2-Yl)Morpholine balances classic heterocyclic chemistry with functional group versatility and win-win physical properties. The bromine handle supports bread-and-butter cross-coupling, while the morpholine and pyridine rings invite broad derivatization. By standing out against more limited alternatives, this reagent finds utility across medicinal, material, and high-throughput chemistry alike.
Raised standards of reporting and safety, coupled with responsible waste handling, make it more than just a routine bench chemical. With consistent performance, competitive economics, and a track record shown through both published literature and real-life experiments, it earns its place in the reagent roster of forward-thinking research groups. As research shifts to more complex targets and higher-throughput workflows, compounds like 4-N-(5-Bromopyridin-2-Yl)Morpholine bring a welcome blend of practicality and possibility to the table.